McKesson Corporation
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2022 | 2023 | 2024 | 2025 | 2026 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 263.97B | 276.71B | 308.95B | 359.05B | 403.43B | 12.4% | |
| Cost of Revenue | (251.32B) | (264.84B) | (296.75B) | (346.57B) | (388.88B) | 12.2% | |
Gross Profit | 12.65B | 11.87B | 12.20B | 12.48B | 14.55B | 16.5% | |
| Operating Expenses | |||||||
| Research & Development | (70.00M) | (89.00M) | (77.00M) | (91.00M) | (103.00M) | 13.2% | |
| Selling, General & Administrative | (9.86B) | (7.33B) | (8.20B) | (8.02B) | (8.10B) | -200.9% | |
| Depreciation & Amortization | (1.00B) | (857.00M) | (635.00M) | (636.00M) | (729.00M) | 14.6% | |
Operating Income (EBIT) | 2.72B | 4.45B | 3.93B | 4.37B | 6.45B | 47.6% | |
| Non-Operating Items | |||||||
| Interest Income | 10.00M | 107.00M | 118.00M | 173.00M | 179.00M | 3.5% | |
| Interest Expense | (178.00M) | (248.00M) | (243.00M) | (256.00M) | (247.00M) | -3.5% | |
| Other Income/Expenses (Net) | -795.00M | 177.00M | -138.00M | -13.00M | -253.00M | 1846.2% | |
Income Before Tax | 1.93B | 4.63B | 3.79B | 4.36B | 6.20B | 42.3% | |
| Income Tax Expense | (636.00M) | (905.00M) | (629.00M) | (878.00M) | (1.10B) | 25.5% | |
Net Income | 1.11B | 3.56B | 3.00B | 3.29B | 4.76B | 44.5% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $7 | $25 | $23 | $26 | $39 | 49.1% | |
| Weighted Avg Shares Outstanding | 152.30M | 141.10M | 133.20M | 127.40M | 123.60M | -3.0% | |
| Weighted Avg Shares Outstanding (Diluted) | 154.10M | 142.20M | 134.10M | 128.10M | 124.10M | -3.1% | |
EBITDA | 3.11B | 5.74B | 4.67B | 5.25B | 7.18B | 36.7% |
Explore MCK
MCK in the Healthcare
Large Cap